1. Home
  2. DVS vs ALT Comparison

DVS vs ALT Comparison

Compare DVS & ALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DVS
  • ALT
  • Stock Information
  • Founded
  • DVS 2011
  • ALT 1997
  • Country
  • DVS Canada
  • ALT United States
  • Employees
  • DVS N/A
  • ALT N/A
  • Industry
  • DVS
  • ALT Biotechnology: Pharmaceutical Preparations
  • Sector
  • DVS
  • ALT Health Care
  • Exchange
  • DVS Nasdaq
  • ALT Nasdaq
  • Market Cap
  • DVS 401.8M
  • ALT 348.6M
  • IPO Year
  • DVS N/A
  • ALT N/A
  • Fundamental
  • Price
  • DVS $4.13
  • ALT $4.17
  • Analyst Decision
  • DVS
  • ALT Strong Buy
  • Analyst Count
  • DVS 0
  • ALT 7
  • Target Price
  • DVS N/A
  • ALT $16.33
  • AVG Volume (30 Days)
  • DVS 775.6K
  • ALT 2.9M
  • Earning Date
  • DVS 11-21-2025
  • ALT 11-06-2025
  • Dividend Yield
  • DVS N/A
  • ALT N/A
  • EPS Growth
  • DVS N/A
  • ALT N/A
  • EPS
  • DVS N/A
  • ALT N/A
  • Revenue
  • DVS N/A
  • ALT $20,000.00
  • Revenue This Year
  • DVS N/A
  • ALT N/A
  • Revenue Next Year
  • DVS N/A
  • ALT N/A
  • P/E Ratio
  • DVS N/A
  • ALT N/A
  • Revenue Growth
  • DVS N/A
  • ALT N/A
  • 52 Week Low
  • DVS $2.48
  • ALT $2.90
  • 52 Week High
  • DVS $5.38
  • ALT $10.88
  • Technical
  • Relative Strength Index (RSI)
  • DVS 46.54
  • ALT 55.89
  • Support Level
  • DVS $4.00
  • ALT $3.73
  • Resistance Level
  • DVS $4.49
  • ALT $4.35
  • Average True Range (ATR)
  • DVS 0.22
  • ALT 0.22
  • MACD
  • DVS 0.03
  • ALT 0.02
  • Stochastic Oscillator
  • DVS 45.98
  • ALT 69.84

About DVS Dolly Varden Silver Corporation Common Shares

Dolly Varden Silver Corp is a mineral exploration company. The company's primary business is the acquisition, exploration, evaluation, and development of exploration and evaluation assets. It is focused on exploration advancing the Kitsault Valley Project, which includes the Dolly Varden property and the Homestake Ridge property located in the Golden Triangle of British Columbia, Canada.

About ALT Altimmune Inc.

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

Share on Social Networks: